Effect of a Butyrate Enema on the Systemic Concentration of Short Chain Fatty Acids

NCT02271802 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2014-10-22

No results posted yet for this study

Summary

In this placebo-controlled randomized parallel study the effects of a butyrate enema on plasma short-chain fatty acids (SCFA) concentrations and fluxes from portal drained viscera, liver and the splanchnic area are investigated

Conditions

  • SCFA Metabolism

Interventions

DIETARY_SUPPLEMENT

Sodium butyrate

Patients recieved an enema containing butyrate or a placebo during upper abdominal surgery.

DIETARY_SUPPLEMENT

NaCl

Sponsors & Collaborators

  • Top Institute Food and Nutrition

    collaborator OTHER
  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • CHC Dejong, MD, PhD · Maastricht University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02271802 on ClinicalTrials.gov